Werle, B <br/><br/>
Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.  [electronic resource] 

 -  Anticancer research   
 - 4147-61 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Analysis of Variance<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Non-Small-Cell Lung--enzymology<br/>Cathepsin B--metabolism<br/>Female<br/>Humans<br/>Lung Neoplasms--enzymology<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Plasminogen Activator Inhibitor 1--metabolism<br/>Receptors, Cell Surface--metabolism<br/>Receptors, Urokinase Plasminogen Activator<br/>Survival Rate